The net cost of asthma to North Carolina medicaid and the influence of comorbidities that drive asthma costs

Journal of Asthma

Volumn 42, Issue 6, 2005, Pages 469-477

  Sapra, Sandhya ^a   Nielsen, Kirsten ^b   Martin, Bradley C ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Asthma; Cost; Medicaid; Retrospective; Sensitivity analysis

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTHMA; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DRUG COST; FEMALE; GENDER; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RACE DIFFERENCE; SENSITIVITY ANALYSIS; UNITED STATES;

EID: 26944453139     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-200067265     Document Type: Article

References (27)

1. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001; 107:3-8.
2. Weiss ST. Epidemiology and heterogeneity of asthma. Ann Allergy Asthma Immunol 2001; 87(suppl):5-8.
3. Piecoro LT, Potosk M, Talbert JC, Doherty DE. Asthma prevalence, cost and adherence with expert guidelines on the utilization of health care services and costs in state Medicaid population. Health Serv Res 2001; 36(2):357-371.
4. Iryes HT, Anderson GF, Shaffert TJ, Neff JM. Expenditures for care of children with chronic illness enrolled in the Washington State medicaid program, fiscal year 1993. Pediatrics 1997; 100(2):197-204.
5. Eisner M, Ktaz P, Yelin E, Shiboski SC, Blanc PD. Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res 2001; 2(1):53-60.
6. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156(3 Pt 1):787-793.
7. Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003; 21(1):116-122.
8. Phelan-Grupp J, Lazano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidites. J Asthma 2001; 38(4):363-373.
9. Castro-Rodriguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ, Martinez FD. Association of radio logically ascertained pneumonia before age 3 yr with asthma like symptoms and pulmonary function in childhood-a prospective study. Am J Respir Crit Care Med 1999; 159:1891-1897.
10. Joseph KS, Blais L, Ernst P, Suissa S. Increased morbidity and mortality related to asthma among asthmatics patients who use major tranquillizers. BMJ 1996; 12(7023):79-82.
11. Lieu TA, Quesenberry CP, Sorel ME, Mendoza GR, Leong AB. Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med 1999; 157(4 Pt 1):1173-1180.
12. Stempel DA, Durcannin-Robbins JF, Hedblom EC, Woolf R, Sturm LL, Stempel AB. Drug utilization evaluation identifies costs associated with high-use of beta-adrenergic agonists. Ann Allergy Asthma Immunology 1996; 76:153-158.
13. Huse DM, Russell MW, Weiss ST, Hartz SC. Anti-inflammatory therapy reduces total costs of asthma care compared with bronchodilation: the asthma outcomes registry. Am J Manag Care 2000; 6(9):1045-1050.
14. Frischer M, Heatlie H, Chapman S, Norwood J, Bashford J, Millson D. Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker? Public Health 1999; 113(5):247-250.
15. Schatz M, Cook EF, Joshua A, Petitti D. Risk factors for asthma hospitalizations in a managed care organization: development of a clinical prediction rule. Am J Manag Care 2003; 9(8):538-547.
16. Nash DR, Childs GE, Kelleher KJ. A cohort study of resource use by medicaid children with asthma. Pediatrics 1999; 104(2 Pt 1):310-312.
17. Lazano P, Fishman P, VonKroff M, Hecht J. Health care utilization among children with asthma who were enrolled in a health maintenance organization. Pediatrics 1997; 99(6):757-764.
18. Armstrong EP, Malone DC, Rehfeld RA. Cost of treating asthma in a managed care population. Value Health 2001; 4(2):80.
19. Himmel W, Hummers-Pradier E, Schumann H, Kochen MM. The predictive value of asthma medications to identify individuals with asthma-a study in German general practices. Br J Gen Pract 2000; 51(472):879-883.
20. Osborne ML, Vollmer WM, Johnson RE, Buist AS. Use of an automated database to identify individuals with asthma. J Clin Epidemiol 1995; 48(11):1393-1397.
21. Shapiro GG, Bierman WC, Virant FS. The child with asthma. In: Lieberman P, Anderson A, eds. Allergic Diseases: Diagnosis and Treatment. Humana Press, 2000.
22. Leone FT, Grana JR, McDermott P, MacPherson S, Hanchak NA, Fish JE. Pharmaceutically-based severity stratification of an asthmatic population. Respir Med 1999; 93:788-793.
23. Kramarz P, Destefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy SM. Vaccine safety datalink team. Does influence vaccinations prevent asthma exacerbations in children? J Pediatr 2000; 138:306-310.
24. Ricci JF, Dorfman JH, Martin BC. Development and validation of prospective cost risk adjustment indices using administrative medical and drug information for Medicaid populations. Poster Presented at the Academy for Health Services Research and Health Policy. Annual Meeting, Atlanta, GA, June 2001.
25. Pont LG, Werf GTh, Denig P, Ruskamp FM. Identifying general practice patients diagnosed with asthma and their exacerbations episodes from prescribing data. Eur J Clin Pharmacol 2000; 57:819-825.
26. Source: Behavioral Risk Factor Surveillance System, 2000 at http://www.cdc.gov/brfss/. (accessed June 2003).
27. Patterson PE, Harding SM. Gastroesophageal reflux disorders and asthma. Curr Opin Pulm Med 1999; 5(1):63-67.